Metagenomi, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGX and other ETFs, options, and stocks.

About MGX

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform.

CEO

Brian C. Thomas

CEOBrian C. Thomas

Employees

202

Employees202

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2016

Founded2016

Employees

202

Employees202

MGX Key Statistics

Market cap

53.46M

Market cap53.46M

Price-Earnings ratio

-0.68

Price-Earnings ratio-0.68

Dividend yield

—

Dividend yield—

Average volume

492.09K

Average volume492.09K

High today

$1.48

High today$1.48

Low today

$1.39

Low today$1.39

Open price

$1.42

Open price$1.42

Volume

591.17K

Volume591.17K

52 Week high

$6.25

52 Week high$6.25

52 Week low

$1.23

52 Week low$1.23

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own MGX. This list is generated using Robinhood data, and it’s not a recommendation.